Cargando…
CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphoma
INTRODUCTION: Most T cell receptor (TCR)Vβ chain-expressing T cell lymphomas (TCL) including those caused by Human T cell leukaemia virus type-1 (HTLV-1) have poor prognosis. We hypothesised that chimeric antigen receptor (CAR)-mediated targeting of the clonal, lymphoma-associated TCRβ chains would...
Autores principales: | Rowan, Aileen G., Ponnusamy, Kanagaraju, Ren, Hongwei, Taylor, Graham P., Cook, Lucy B. M., Karadimitris, Anastasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019783/ https://www.ncbi.nlm.nih.gov/pubmed/36936927 http://dx.doi.org/10.3389/fimmu.2023.1118681 |
Ejemplares similares
-
Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting
por: Rotolo, Antonia, et al.
Publicado: (2018) -
Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
por: Karadimitris, Anastasios, et al.
Publicado: (2019) -
iNKT: A new avenue for CAR-based cancer immunotherapy
por: Liu, Yilin, et al.
Publicado: (2022) -
NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015) -
iNKT and MAIT Cell Alterations in Diabetes
por: Magalhaes, Isabelle, et al.
Publicado: (2015)